Nilotpal Roy

Vividion Therapeutics (United States) — United States

Medicine · Health Sciences

20h-index2.2kcitations71works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(38), Pancreatitis Pathology and Treatment(18), Cancer Cells and Metastasis(10), DNA Repair Mechanisms(9), Pancreatic function and diabetes(8)

Publications71 total

A covalent allosteric molecular glue suppresses NRF2-dependent cancer growth
Cancer Discovery·2025Open Access
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2
Science·2025· 1 citedOpen Access
Covalent inhibitors of the RAS binding domain of PI3Kα impair tumor growth driven by RAS and HER2
2024· 1 citedOpen Access
Suppression of NRF2-dependent cancer growth by a covalent allosteric molecular glue
2024· 11 citedOpen Access
233 (PB221): Therapeutic targeting of NRF2 increases sensitivity to chemotherapy in various solid tumors
European Journal of Cancer·2024
Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
Nature Medicine·2023· 3 citedOpen Access
Supplementary Table S1 from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplementary Figure S1-S9. from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplementary Table S3 from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplementary Table S2 from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Data from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplemental Methods and Materials from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplemental Methods and Materials from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Data from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplementary Figure S1-S9. from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplementary Table S4 from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplementary Table S5 from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplementary Table S3 from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplementary Table S6 from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
Supplementary Table S1 from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Matthias Hebrok(27), Grace Kim(15), Pradip Raychaudhuri(12), Srilata Bagchi(11), Sam L. Ivry(11), Dana A. Dominguez(11), Stacy E. Hatcher(11), Anthony J. O’Donoghue(11), Charles S. Craik(11), Jeremy Sharib(10), Michele Yip-Schneider(10), Randall E. Brand(10), Walter G. Park(10), Kimberly S. Kirkwood(10), Dragana Kopanja(8), C. Max Schmidt(8), Christine A. Iacobuzio–Donahue(7), Tanya Stoyanova(6), Benjamin D. Horning(5), Gabriel M. Simon(5)